13.05.2022 Views

BREAST CYTOPATHOLOGY

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Technical Aspects 7

Pitfalls in the diagnosis of breast lesions can result from

poor preparation, inadequately sampled lesions, or lack of

communication between the person who aspirates the lesion

and the one who interprets the cytology. Some of the limitations

of this procedure include the inability to distinguish in

situ from invasive carcinoma, the need to evaluate further by

tissue biopsy, all atypical gray zone lesions, and the lack of

specific cytologic diagnoses for the majority of benign

lesions.

All cytology reports should contain a statement of adequacy.

This is true for the breast as well. The phrases “unsatisfactory

for interpretation,” “negative for malignant cells,”

“atypical/indeterminate,” “suspicious for malignancy,” and

“positive for malignant cells” describe the categories often

used with added statements explaining further findings.

“Unsatisfactory” is used for various reasons: poor technique,

obscuring blood or inflammation, paucicellular material,

and so forth. We do not encourage the use of microscopic

descriptions when a specimen is unsatisfactory for interpretation.

This could lead to misunderstanding on the part of the

clinician reading the report. Benign is used for neoplastic

as well as non-neoplastic conditions. For example: Negative

for malignant cells: mastitis. Or, negative for malignant cells:

fibroadenoma.

“Atypical cells present/indeterminate” indicates that the

specimen is abnormal but cannot be further defined. This

usually leads to additional diagnostic procedures. “Suspicious

for malignant cells” is used when the suspicion of malignancy

is great but perfect criteria are lacking; there may be few cells

present or obscuring material. The type of malignancy suspected

should be stated, that is, ductal carcinoma, sarcoma,

and so forth. This category is considered positive for quality

assurance and review purposes. “Positive for malignant cells”

is used when malignancy is certain. Again, the type of malignancy

present should be clearly stated.

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!